Pure Global

Evaluation of L-PRF as an Antibiotic Slow-release Biological Device in the Treatment of Moderate Periodontitis - Trial NCT06153706

Access comprehensive clinical trial information for NCT06153706 through Pure Global AI's free database. This Phase 2/3 trial is sponsored by Yasmeen Khaled and is currently Completed. The study focuses on Periodontitis. Target enrollment is 24 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06153706
Phase 2/3
Completed
drug
Trial Details
ClinicalTrials.gov • NCT06153706
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Evaluation of L-PRF as an Antibiotic Slow-release Biological Device in the Treatment of Moderate Periodontitis
Evaluation of L-PRF as an Antibiotic Slow-release Biological Device in the Treatment of Moderate Periodontitis (A Randomized Controlled Clinical Trial)

Study Focus

Periodontitis

Subgingival application of L-PRF loaded with metronidazole

Interventional

drug

Sponsor & Location

Yasmeen Khaled

Alexandria University

Alexandria, Egypt

Timeline & Enrollment

Phase 2/3

Jun 01, 2022

Oct 01, 2023

24 participants

Primary Outcome

Plaque accumulation,Gingival inflammation,Bleeding on probing,Probing depth,Clinical attachment loss,Quantitative assessment of Porhyromonas gingivalis

Summary

This study aimed to evaluate the efficacy of leukocyte platelet-rich fibrin (L-PRF) as a
 local sustained released device for antibiotics.

ICD-10 Classifications

Chronic periodontitis
Periodontosis
Acute periodontitis
Chronic apical periodontitis
Periodontal disease, unspecified

Data Source

ClinicalTrials.gov

NCT06153706

Non-Device Trial